| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824813 | Clinical Therapeutics | 2015 | 9 Pages |
Abstract
DMF is an effective and well tolerated therapy for RRMS. In addition to clinical benefits, the use of DMF may be associated with reduced patient burden and health economic savings, resulting from a decrease in resource utilization associated with relapses. ClinicalTrials.gov identifiers: NCT00420212 and NCT00451451.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Gavin MBBCh, Ralf MD, Robert J. MD, Ludwig MD, Mariko MD, Minhua MS, Sujata P. PhD, Ray PhD, Vissia MD, PhD, Eva MD,